Resources
New Reports Show Medicare Drug Prices Are High and Rising Rapidly
- Organization: Committee on Government Reform: Minority Office
- Document Type: Article/News
- Date Created: Tuesday, February 28, 2006
- Submitted: Tuesday, February 28, 2006
- Attachment(s): LINK
From the website:
Rep. Waxman releases three new reports that show (1) Medicare drug plans have raised prices for popular brand-name drugs by more than 4% since January 1; (2) Medicare drug plans now charge 14% more for these drugs than the discredited Medicare drug cards previously charged; and (3) Medicare drug card providers negotiated negligible discounts of at most 3% to 5% from drug manufacturers. One of the three reports was prepared by GAO; it also finds that the Administration had advance warning that its systems would not be able to reconcile enrollment and eligibility data satisfactorily.
Rep. Waxman releases three new reports that show (1) Medicare drug plans have raised prices for popular brand-name drugs by more than 4% since January 1; (2) Medicare drug plans now charge 14% more for these drugs than the discredited Medicare drug cards previously charged; and (3) Medicare drug card providers negotiated negligible discounts of at most 3% to 5% from drug manufacturers. One of the three reports was prepared by GAO; it also finds that the Administration had advance warning that its systems would not be able to reconcile enrollment and eligibility data satisfactorily.
